全球納米毒性和安全市場

全球納米毒性和安全市場分析為 6240 萬美元，預計到 2027 年將達到 1.516 億美元，從 2022 年到 2027 年的複合年增長率為 16.61%。

按技術來看，掃描電子顯微鏡細分市場將在 2021 年佔據最大的市場份額，收入為 4368 萬美元。

按工藝來看，2021 年物理化學工藝細分市場的市場份額略高於形態工藝。

通過毒性測試，細胞培養（體外）部分在 2021 年佔據了市場份額。

就納米粒子而言，2021 年的大部分市場份額將來自二氧化鈦納米粒子領域。各種類型的基於氧化鈦的納米顆粒可以通過四種不同的晶體結構進行區分：金紅石、銳鈦礦、板鈦礦和二氧化鈦，其中金紅石和銳鈦礦是消費品中最常用的。

就毒性而言，納米毒性和安全市場在 2021 年看到劑量依賴性毒性部分產生的收入最多。

從應用來看，醫藥板塊在預測期內將保持優勢，並將通過納米技術在藥物輸送、癌症和動脈硬化等疾病的成像和診斷以及聽力和視力障礙等方面的應用，繼續實現穩定增長。已被分析成長為

按地區劃分，北美地區將在 2021 年佔據壓倒性的市場份額。由於生命科學、農業、工業能源和其他領域的各種研發活動對納米毒性測試設備的需求不斷增長，以及該地區主要參與者的強大存在，美國是該市場的最大收入貢獻者。

內容

第 1 章納米毒性和安全市場：概述

第 2 章納米毒性和安全市場：執行摘要

第 3 章納米毒性和安全市場：景觀

• 市場份額分析：主要參與者
• 產品比較：主要公司
• 財務分析：前 5 名公司
• 專利分析：主要公司
• 價格分析

第四章納米毒性與安全市場的影響因素

• 市場驅動力
• 市場製約因素
• 市場機會
• 波特五力分析
  • 供應商的議價能力
  • 客戶議價能力
  • 新進入者的威脅
  • 現有公司之間的競爭關係
  • 替代產品的威脅

第 5 章納米毒性和安全市場：戰略分析

• 價值鏈分析
• 市場機會分析
• 市場生命週期
• 供應商/分銷商分析

第 6 章納米毒性和安全市場：按技術分類（市場規模（十億美元））

• 掃描電子顯微鏡 (SEM)
• 透射電子顯微鏡
• 其他（X 射線衍射、熱分析）

第 7 章納米毒性和安全性市場：按生物系統（市場規模（單位：十億美元））

• 單元格
• 組織
• 生物

第 8 章納米毒性和安全市場：按工藝（市場規模（十億美元））

• 形態過程
• 物理化學過程

第 9 章納米毒性和安全市場：通過毒性測試（市場規模（十億美元））

• 細胞培養（體外）
  • 二維模型
  • 3D 模型
• 有機體（體內）
  • 水生生物模型
  • 小型囓齒動物（哺乳動物模型）

第 10 章納米毒性和安全性市場：按納米粒子（市場規模（十億美元））

• 二氧化鈦納米粒子
• 銀納米粒子
• 其他

第 11 章納米毒性和安全市場：按毒性（市場規模（單位：十億美元））

• 尺寸依賴性毒性
• 表面依賴性毒性
• 形狀依賴性毒性
• 聚集/聚集依賴性毒性
• 劑量依賴性毒性

第 12 章納米毒性和安全性市場：按應用（市場規模（十億美元））

• 能源
• 材料/健康
• 醫療系統
• 農業
• 藥品
• 化妝品
• 其他（工程/食品/其他）

第 13 章納米毒性和安全市場：按地區（市場規模（十億美元））

• 北美
  • 美國
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 哥倫比亞
  • 其他南美國家
• 歐洲
  • 英國
  • 德國
  • 意大利
  • 法國
  • 西班牙
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳大利亞和新西蘭
  • 其他亞太國家

第 14 章納米毒性和安全市場：熵

• 推出新產品
• 併購 (M&A)、業務合作/合夥、合資

第 15 章納米毒性和安全市場：公司分析

• 市場份額、公司收益、產品、併購 (M&A)、趨勢
• 分析公司（共 10 家公司）

Nano Toxicity and Safety refers to the potential adverse health effects related to engineered nanomaterial exposure and different techniques, tools, and approaches related to the safety of nanotechnology. The nanoparticles' potential for danger is evident due to the high surface area to volume ratio, which can make them highly reactive or catalytic. In addition, they can pass through cell membranes in organisms and may interact with biological systems. The global Nano Toxicity and Safety Market is analyzed to be $62.4 million and is projected to reach $151.6 million in 2027, growing with a CAGR of 16.61 % during 2022-2027. The Nano Toxicity and Safety market is segmented by technique, by process, by toxicity test, by nano particles, by toxicity, and by application in this report. The market is also segmented by geography, which include North America, South America, Europe, and Asia-Pacific.

Nano Toxicity and Safety Market Segment Analysis - By Technique

Nano Toxicity and Safety Market is segmented by technique such as Scanning Electron Microscopy, Transmission Electron Microscopy, and Others (X-ray Diffraction, Thermal Analysis). In 2021, the Scanning Electron Microscopy segment held the greatest market share, generating $43.68 million. Depending on the size and substance used to create nanomaterialss, scanning electron microscopy and transmission electron microscopy are two microscopic methods that characterize morphology. Studies using scanning electron microscopy (SEM) and transmission electron microscopy (TEM) have been carried out to learn more about the morphology, structure, and size of IO-NPs.

Nano Toxicity and Safety Market Segment Analysis - By Process

In terms of process, the Physicochemical Process segment achieved slightly bigger market share of the Nano Toxicity and Safety Market in 2021 than Morphological Process. Nanotoxicology is based on a variety of factors, including size, surface area, morphology, composition, surface chemistry, aggregation/agglomeration phenomena, etc. The interaction of Nanomaterials with biological cells is greatly impacted by their morphological and physicochemical characteristics, which may also affect their toxicity.

Nano Toxicity and Safety Market Segment Analysis - By Toxicity Test

In terms of toxicity test, the Cell Cultures (In Vitro) segment dominated the market share in 2021. The Cell Cultures (In Vitro) segment can be subcategorized into 2D models and 3D models. The most popular technique for determining NM toxicity on a 2D platform involves exposing adherent cells to an NM dispersion where the NMs are dispersed in the media.

Nano Toxicity and Safety Market Segment Analysis - By Nanoparticle

By nanoparticle, the majority of market share in 2021 was from the Titanium Dioxide Nanoparticles segment. Materials use titanium dioxide (TiO2) in a variety of ways such as paper, plastic, ceramics, rubber, printer ink, floor coverings, catalysts, fabrics and textiles, cosmetics, food colors, medicines, paints, coatings, and electronic components. Four different crystalline structures-rutile, anatase, brookite, or titanium dioxide-can be used to distinguish the various types of TiO2-based NMs, with rutile and anatase being the most frequently used in consumer goods.

Nano Toxicity and Safety Market Segment Analysis - By Toxicity

By toxicity, Nano Toxicity and Safety Market is segmented into Size-dependent Toxicity, Surface-dependent Toxicity, Shape-dependent Toxicity, Aggregation or agglomeration-dependent Toxicity and Dose-dependent Toxicity. As one of the critical factors affecting toxicity, the Dose-dependent Toxicity segment generated the most revenue in 2021 Nano Toxicity and Safety market. To determine the minimum dose of NPs which is induces toxicity, dose is very important.

Nano Toxicity and Safety Market Segment Analysis - By Application

Nano Toxicity and Safety Market is segmented by its various application such as Energy, Materials and Health, Medical Systems, Agriculture, Pharmaceutical, Cosmetic, and Others (Engineering, Food and Others). The Pharmaceutical segment is analyzed to hold the dominance and to grow steadily during the forecast period owing to the utilization of nanotechnology in drug delivery, imaging & diagnosis of diseases such as cancer and atherosclerosis, as well as hearing & vision disorders. Thus, the importance of nanomaterial toxicity testing is more highlighted.

Nano Toxicity and Safety Market Segment Analysis - By Geography/Country

The report comprises of the region wise study of the global market including North America, South America, Europe, and Asia-Pacific. Among them, North America region accounted for the dominant market share in 2021. The United States contributes to the most revenue to the market with growing need for nano-toxicity testing devices for various research and development activities in the sectors of Life Science, Agriculture, Industrial Energy, and others as well as the strong presence of key players in this region.

Nano Toxicity and Safety Market- Drivers

One of the primary factors driving the growth in global Nano Toxicity and Safety market is emerging technological advancements in nanotechnology and nanotech devices. Some of advanced nanotechnologies are nano-identification, nano-impact, nano-scratch, and nano-tribological, and they are now used in many testing procedures to better understand materials at the nanoscale. Based on the advanced nanotechnologies, increase in adoption of Nano-toxicology testing in various end-use industries such as the energy, healthcare, cosmetic industry, and others is set to propel the market growth.

Nano Toxicity and Safety - Competitive Landscape

Major companies in the global Nano Toxicity and Safety Market profiled in this report include Horiba, CytoViva, Schaefer-Tec AG, Thermo Fisher Scientific, Carl Zeiss NTS Ltd., Hitachi High-Technologies Corporation, SGS SA, Eurofins Scientific, Charles River Laboratories International Inc., Enviroscience Inc. Technology launches, acquisitions, partnerships and R&D activities are key strategies adopted by the key players in the Nano Toxicity and Safety market.

Nano Toxicity and Safety - Recent Developments

In May 2022, HORIBA UK announces that it has joined the lifETIME Centre for Doctoral Training (CDT) as an Industry Partner. This partnership aims to provide a new generation of scientists with skills and approaches to reduce and replace the need for animal testing, so transforming drug discovery, toxicology screening and regenerative medicine.

In August 2021, Eurofins Discovery, a leading provider of products and services to the drug discovery industry and a Eurofins Scientific company, announced a new commercial collaboration with Fusion Antibodies plc, a specialist in the pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications.

In November 2020, Carl Zeiss NTS Ltd presented a new generation of its field emission scanning electron microscope (FESEM) family ZEISS GeminiSEM. The new models ZEISS GeminiSEM 360, 460 and 560 are tailored for sub-nanometer imaging and effortless analytics. Users benefit from innovations in the electron optics and a new chamber design offering better image quality, usability and flexibility. ZEISS GeminiSEM 560 now being introduced brings the ZEISS Gemini 3 column to the market for the first time.

Nano Toxicity and Safety - Report Scope and Coverage

The base year of the study is 2021, with forecast done up to 2027. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. These provide the key market participants with the necessary business intelligence and help them understand the future of the Nano Toxicity and Safety market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, and Nano Toxicity and Safety manufacturing method analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the key global Nano Toxicity and Safety Market players, to define, describe and analyze the sales value, market share, SWOT analysis and development plans in upcoming years.

By Technique: Scanning Electron Microscopy, Transmission Electron Microscopy, Others (X-ray Diffraction, Thermal Analysis)

By Process: Morphological Process, Physicochemical Process

By Toxicity Tests: Cell Cultures (In Vitro) (2D Models & 3D Models), Living Organisms (In Vivo) (Aquatic Models, Small Rodents)

By Nanoparticles: Titanium Dioxide Nanoparticles, Silver Nanoparticles, Others

By Toxicity: Size-dependent Toxicity, Surface-dependent Toxicity, Shape-dependent Toxicity, Aggregation or agglomeration-dependent Toxicity, Dose-dependent Toxicity

By Application: Energy, Materials and Health, Medical Systems, Agriculture, Pharmaceutical, Cosmetic, Others (Engineering, Food and Others)

By Region: North America, South America, Europe, Asia-Pacific

Table of Contents

1. Nano Toxicity and Safety Market- Market Overview

• 1.1 Definitions and Scope

2. Nano Toxicity and Safety Market- Executive Summary

• 2.1 Market Revenue, Market Size and Key Trends by Company

3. Nano Toxicity and Safety Market- Landscape

• 3.1 Market Share Analysis- Top Companies
• 3.2 Product Benchmarking- Top Companies
• 3.3 Top 5 Financials Analysis
• 3.4 Patent Analysis- Top Companies
• 3.5 Pricing Analysis

4. Nano Toxicity and Safety Market- Market Forces

• 4.1 Market Drivers
• 4.2 Market Constraints
• 4.3 Market Opportunities
• 4.4 Porters five force model
  • 4.4.1 Bargaining power of suppliers
  • 4.4.2 Bargaining powers of customers
  • 4.4.3 Threat of new entrants
  • 4.4.4 Rivalry among existing players
  • 4.4.5 Threat of substitutes

5. Nano Toxicity and Safety Market -Strategic analysis

• 5.1 Value chain analysis
• 5.2 Opportunities analysis
• 5.3 Market life cycle
• 5.4 Suppliers and distributors Analysis

6. Nano Toxicity and Safety Market- By Technique (Market Size -$Billion)

• 6.1 Scanning Electron Microscopy
• 6.2 Transmission Electron Microscopy
• 6.3 Others (X-ray Diffraction, Thermal Analysis)

7. Nano Toxicity and Safety Market- By Biological Systems (Market Size -$Billion)

• 7.1 Cells
• 7.2 Tissues
• 7.3 Living Organisms

8. Nano Toxicity and Safety Market- By Process (Market Size -$Billion)

• 8.1 Morphological Process
• 8.2 Physicochemical Process

9. Nano Toxicity and Safety Market- By Toxicity Tests (Market Size -$Billion)

• 9.1 Cell Cultures (In Vitro)
  • 9.1.1 2D Models
  • 9.1.2 3D Models
• 9.2 Living Organisms (In Vivo)
  • 9.2.1 Aquatic Models
  • 9.2.2 Small Rodents (Mammal models)

10. Nano Toxicity and Safety Market- By Nanoparticles (Market Size -$Billion)

• 10.1 Titanium Dioxide Nanoparticles
• 10.2 Silver Nanoparticles
• 10.3 Others

11. Nano Toxicity and Safety Market- By Toxicity (Market Size -$Billion)

• 11.1 Size-dependent Toxicity
• 11.2 Surface-dependent Toxicity
• 11.3 Shape-dependent Toxicity
• 11.4 Aggregation or agglomeration-dependent Toxicity
• 11.5 Dose-dependent Toxicity

12. Nano Toxicity and Safety Market- By Application (Market Size -$Billion)

• 12.1 Energy
• 12.2 Materials and Health
• 12.3 Medical Systems
• 12.4 Agriculture
• 12.5 Pharmaceutic
• 12.6 Cosmetic
• 12.7 Others (Engineering, Food and Others)

13. Nano Toxicity and Safety Market - By Geography (Market Size -$Billion)

• 13.1 North America
  • 13.1.1 U.S.
  • 13.1.2 Canada
  • 13.1.3 Mexico
• 13.2 South America
  • 13.2.1 Brazil
  • 13.2.2 Argentina
  • 13.2.3 Colombia
  • 13.2.4 Rest of South America
• 13.3 Europe
  • 13.3.1 U.K
  • 13.3.2 Germany
  • 13.3.3 Italy
  • 13.3.4 France
  • 13.3.5 Spain
  • 13.3.6 Rest of Europe
• 13.4 Asia Pacific
  • 13.4.1 China
  • 13.4.2 India
  • 13.4.3 Japan
  • 13.4.4 South Korea
  • 13.4.5 Australia & New Zealand
  • 13.4.6 Rest of Asia Pacific

14. Nano Toxicity and Safety Market- Entropy

• 14.1 New Product Launches
• 14.2 M&A's, Collaborations, JVs and Partnerships

15. Nano Toxicity and Safety Market Company Analysis

(Market Share, Company Revenue, Products, M&A, Developments)

• 15.1 Company 1
• 15.2 Company 2
• 15.3 Company 3
• 15.4 Company 4
• 15.5 Company 5
• 15.6 Company 6
• 15.7 Company 7
• 15.8 Company 8
• 15.9 Company 9
• 15.10 Company 10

"*Financials would be provided on a best-efforts basis for private companies"